Menelas Nicolas Pangalos

Menelas Nicolas Pangalos

Director/Board Member at BIOGEN INC.

Net worth: 2 M $ as of 31/05/2026

59 year
Health Technology
Commercial Services
Consumer Services

Profile

Menelas N. Pangalos is EVP-Biopharmaceuticals Research & Development at AstraZeneca Plc, Member of Society For Neuroscience and Member of British Pharmacological Society and on the board of 5 other companies. In his past career Dr. Pangalos occupied the position of Chief Scientific Officer & Senior Vice President at Neuroscience Research Australia. He received an undergraduate degree from Imperial College London and a doctorate from the University of London.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
04/06/2026 242,408 ( 0.16% ) 2 M $ 31/05/2026
09/06/2026 3,875 ( 0% ) 759 500 $ 31/05/2026

Menelas Nicolas Pangalos active positions

CompaniesPositionStart
ABSCI CORPORATION Director/Board Member 01/01/2024
BIOGEN INC. Director/Board Member 01/01/2025
Director/Board Member -
Private Equity Investor 01/06/2024
Director/Board Member -
Director/Board Member -
Director/Board Member -
Corporate Officer/Principal -
Corporate Officer/Principal -

Former positions of Menelas Nicolas Pangalos

CompaniesPositionEnd
░░░░░░░░░░░ ░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
See the detail of Menelas Nicolas Pangalos's experience

Training of Menelas Nicolas Pangalos

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

80

1st degree connections

18

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies18

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Consumer Services

Consumer Services

Commercial Services

Commercial Services

Commercial Services

Miscellaneous

Commercial Services

Finance

Miscellaneous

Consumer Services

Health Technology

Health Technology

Commercial Services

  1. Stock Market
  2. Insiders
  3. Menelas Nicolas Pangalos